Certara to Report Third Quarter 2021 Financial Results on November 9th, 2021
October 19, 2021 08:00 ET
|
Certara
PRINCETON, N.J., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of...
Certara 推出全新 Synchrogenix™ Writer 软件，加速监管审批流程
October 12, 2021 23:40 ET
|
Certara USA, Inc.
新泽西州普林斯顿, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Certara 为全球生物模拟领域的领军企业，今日宣布推出一款全新的监管 SaaS 产品——Synchrogenix™ Writer。该产品可加快患者叙述的撰写和审查速度。患者叙述描述了不良事件或药物不良反应，对于整个临床阶段的每个治疗领域的临床研究报告都至关重要。 ...
Certara Appoints Patrick F. Smith to President of Integrated Drug Development
October 12, 2021 08:00 ET
|
Certara
PRINCETON, N.J., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the appointment of Patrick F. Smith, Pharm.D. as president of...
Certara 完成对Pinnacle 21 的收购
October 11, 2021 22:12 ET
|
Certara USA, Inc.
新泽西州普林斯顿, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Certara, Inc.（纳斯达克代码：CERT）为全球生物模拟领域的领军企业，今日宣布完成此前公布的 Pinnacle 21 收购交易，Pinnacle 21 为面向临床数据拟合、监管合规和审批准备的 SaaS 解决方案领先提供商。该交易完成后，Pinnacle 21 的股权持有人获得了约 2.5...
Certara Appoints Drayton T. Virkler as Chief Commercial Officer
October 05, 2021 08:00 ET
|
Certara
PRINCETON, N.J., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the appointment of Drayton T. Virkler to the newly created position...
Certara Completes Acquisition of Pinnacle 21
October 04, 2021 08:00 ET
|
Certara
PRINCETON, N.J., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the completion of the previously announced transaction to acquire...
Certara Launches New Synchrogenix™ Writer Software to Accelerate the Regulatory Submission Process
September 30, 2021 16:30 ET
|
Certara
PRINCETON, N.J., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Certara, a global leader in biosimulation, today announced the launch of Synchrogenix™ Writer, a new regulatory SaaS product that expedites the...
Certara 获得 FDA 的研究基金用于进一步推进生物模拟技术在仿制药虚拟生物等效性评估中的应用
September 23, 2021 00:42 ET
|
Certara USA, Inc.
新泽西州普林斯顿, Sept. 23, 2021 (GLOBE NEWSWIRE) -- 作为生物模拟领域的全球领军者，Certara（纳斯达克股票代码：CERT）今天宣布获得美国食品药品监督管理局 (FDA) 的研究基金，以验证并扩展用于评估虚拟生物等效性 (VBE) 的生物模拟模型，进而有助于促进更安全、更快速且更具性价比的仿制药开发。 生物等效性 (BE)...
Certara Announces New Clinical Science Group and Adds Senior Scientific Experts
September 22, 2021 08:00 ET
|
Certara
PRINCETON, N.J., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Certara, a global leader in biosimulation, today announced that it is expanding its Integrated Drug Development (IDD) division with a new clinical...
Certara Awarded FDA Grant to Further Advance Virtual Bioequivalence Assessments of Generic Medicines Using Biosimulation
September 20, 2021 08:00 ET
|
Certara
PRINCETON, N.J., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Certara (Nasdaq: CERT), a global leader in biosimulation, today announced the Company has been awarded a grant from the U.S. Food and Drug...